Related Experiment Video
Updated: Jun 5, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Rates, Risk Factors and Outcomes of Complications After COVID-19 in Children
Mallika Rattanawijit1, Arisara Samutpong2, Nopporn Apiwattanakul3
1From the Department of Pediatrics, Lampang Hospital, Lampang.
Insights
Long COVID in children is uncommon, affecting approximately 20.4% of cases. Risk factors include anosmia and a history of pneumonia, necessitating follow-up for persistent symptoms.
Area of Science:
- Pediatric Infectious Diseases
- Public Health Virology
Background:
- Coronavirus disease 2019 (COVID-19) can cause significant complications in children, including multisystem inflammatory syndrome in children (MIS-C) and post-COVID-19 conditions (long COVID).
- Understanding the incidence and risk factors for these conditions is crucial for pediatric healthcare.
Purpose of the Study:
- To determine the rates, risk factors, and outcomes of MIS-C and long COVID in children diagnosed with COVID-19.
- To compare these outcomes with children infected with other respiratory viruses.
Main Methods:
- A combined retrospective and prospective cohort study enrolled 618 children (0-18 years) diagnosed with COVID-19 or another respiratory virus between October 2021 and April 2022.
- Demographic, clinical data, and persisting symptoms at 1-12 months post-infection were recorded. MIS-C and long COVID were defined using CDC and WHO criteria.
Main Results:
- The rate of persisting symptoms was 16.5% in COVID-19 patients versus 1.1% in other respiratory virus patients. The rate of MIS-C was 0.7%.
- Long COVID rates were 20.4% (CDC) and 13.0% (WHO). Respiratory symptoms were most common. Risk factors included age 5-18, anosmia, prior pneumonia, and infection during Delta/Omicron waves.
Conclusions:
- Long COVID is uncommon in children following COVID-19 infection.
- Children experiencing anosmia or a history of pneumonia during COVID-19 warrant close follow-up for potential long COVID development.
Background:
Coronavirus disease 2019 (COVID-19) can lead to various complications, including multisystem inflammatory syndrome in children (MIS-C) and post-COVID-19 conditions (long COVID). This study aimed to determine the rates, risk factors and outcomes of MIS-C and long COVID in children previously diagnosed with COVID-19.
Methods:
This study was a combined retrospective and prospective cohort study. Patients 0-18 years of age diagnosed with COVID-19 or another respiratory virus infection were enrolled between October 2021 and April 2022. Demographic and clinical data were reviewed. Information on persisting symptoms and their impacts were recorded at 1-3, 3-6 and 6-12 months after infection. Laboratory investigations and chest imaging examinations were performed during follow-up. MIS-C and long COVID were defined according to the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) definitions.
Results:
A total of 618 patients were enrolled, comprising 437 (70.7%) with COVID-19 and 181 (29.3%) with another respiratory virus infection. At 1-3 months, the rate of persisting symptoms was 16.5% in patients with COVID-19, compared with 1.1% in patients with another respiratory virus infection. The rate of MIS-C was 0.7%. The rate of long COVID according to the CDC and WHO definitions were 20.4% and 13.0%, respectively. Respiratory systems were most affected in long COVID. Age 5-18 years, anosmia during COVID-19, history of pneumonia and infection during the delta and omicron waves were associated with long COVID in children.
Conclusions:
Long COVID after COVID-19 in children is uncommon. Children with anosmia and a history of pneumonia during COVID-19 require follow-up for long COVID.
Related Concept Videos
Pneumonia III: Complications and Assessment
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Asthma-III: Symptoms and Complications
Classification of Asthma
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

